EXHIBITION PREVIEW
with BioMaxima, bringing two important additions to the UK microbiology market – and visitors to the BSMT Annual Microbiology Conference in May will be among the first to see both on display. Already available through Pro-
Menarini Diagnostics.
Menarini Diagnostics The Menarini stand at the BSMT Conference will be showcasing the Coyote FlashDetect; a scalable rapid PCR device enabling users to gain high quality results within 35 minutes. Deliver rapid, reliable results across
a wide range of assays – from hospital- acquired infections to emerging global threats. Get norovirus results in record time to enable swift patient isolation and outbreak prevention, or identity MRSA resistance within minutes after a blood culture botle flags positive. Menarini’s respiratory portfolio offers multiplex PCR for multiple respiratory viruses in a single test. Mycobacterium tuberculosis can be confirmed using the compact Coyote FlashDetect Nano, designed to fit seamlessly inside a category 3 cabinet. With an ever-expanding assay menu – including five new additions in the last few months – Coyote FlashDetect keeps your laboratory at the cuting edge.
www.menarinidiag.co.uk
Pro-Lab Diagnostics Pro-Lab Diagnostics UK is delighted to announce an expanding partnership
Lab are BioMaxima’s innovative MIC strips, designed to determine the minimum inhibitory concentration of antibiotics with exceptional consistency and accuracy. Manufactured using a patented biomedical composite material – developed in collaboration with Arctic Paper – the strips’ reinforced carrier layer ensures precise antibiotic diffusion and highly reproducible results, supporting clinicians in selecting targeted antimicrobial therapies and contributing to broader efforts to combat antimicrobial resistance. Joining the portfolio imminently, and
exclusively through Pro-Lab for the UK market, are BioMaxima’s antimicrobial paper discs. Trusted by laboratories worldwide for antimicrobial susceptibility testing and bacterial differentiation, these discs are produced in a state-of-the- art manufacturing environment under rigorous quality control; delivering the consistent, reliable performance that microbiology professionals depend on. Pro-Lab will be showcasing both
products at the BSMT conference. Visit our stand to speak with the team and discover how BioMaxima’s solutions can support your laboratory’s diagnostic needs.
www.pro-lab.co.uk
Qiagen Whether you’re driving research or delivering critical answers to patients, Qiagen’s tools are built for reliability across both infectious diseases and oncology. The EZ2 Connect MDx system, part of Qiagen’s gold-standard sample- prep family, pairs with the QIAcuity digital PCR platform to deliver high-quality extraction and sensitive, multiplexed detection. From studying minimal residual disease to quantifying viral load, this workflow provides consistent results for research activities.
In oncology, Qiagen can help you keep
pace with the growing complexity of cancer research through its partnership with ID Solutions. New oncology assays available on QIAcuity deliver absolute quantification of key biomarkers for scientific research purposes. In infectious disease testing the
QIAstat-Dx Analyzer and QIAstat-Dx Rise platforms offer fast, accurate syndromic testing for respiratory, GI and CNS infections, with medically relevant targets. And when it comes to tuberculosis, QuantiFERON-TB Gold Plus remains the world’s leading IGRA test: Reliable, scalable and easy to implement across care setings.
www.qiagen.com
R-Biopharm Rhône R-Biopharm Rhône is the UK subsidiary of the R-Biopharm Group, a leading manufacturer of solutions for clinical diagnostics. The company offers a wide range of products for multiple applications including gastroenterology, AMR, respiratory pathogens and sexual health. Offering solutions covering molecular multiplexed syndromic testing, Rapid lateral flow and ELISA-based assays R-Biopharm’s trademark brands including RIDA GENE and RIDA QUICK are recognised around the world for providing reliable and quality results.
www.r-biopharm.com
Serosep Serosep will be showcasing its flagship molecular diagnostic platform, EntericBio, which continues to transform the detection of bacterial, viral, and parasitic pathogens directly from stool samples. Designed with the busy clinical laboratory in mind, EntericBio delivers rapid, reliable results and streamlined workflow without the need for complex DNA extraction. In addition to its own innovations,
Serosep is the trusted distributor of several world-class diagnostic brands. Visit the stand to explore key solutions from Bio-Rad Laboratories, specifically infectious disease diagnostics. The firm
R-Biopharm Rhône.
Pro-Lab Diagnostics. 48
WWW.PATHOLOGYINPRACTICE.COM April 2026
Qiagen.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
